TGF β 1 Expression Related Gene Polymorphism and Their Association With Clinical Types of Leprosy

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Observational
SUMMARY

Leprosy is one of the oldest human infectious diseases. It is a chronic infectious contagious, granulomatous disease caused by intracellular bacillus. Mycobacterium leprae, this chronic granulomatous disease presents symptoms that mainly affected the skin, the nervous system and the reticuloendothelial system, also other systems can be affected, such as the upper respiratory tract, bones and joints, eyes and adrenal glands. TGF- β is a pleiotropic cytokine that employs several functions on different types of cells. The effect of other cytokines may finally modulate the cellular response in the presence of TGF- β, causing a different effect depending on the activation state of the cell involved. In addition, TGF- β promotes the healing of inflamed tissue through the stimulation and regulation of extracellular matrix by fibroblasts, in addition to inducing the proliferation of endothelial cells required for angiogenesis. Thus, TGF- β is able to regulate the expression of other growth factors, increasing their level of activity.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 50
Healthy Volunteers: t
View:

• Patients of both sexes with leprosy.

• Age above 18 years.

• patients on multidrug therapy of leprosy.

Locations
Other Locations
Egypt
Aswan Universit Hospital
RECRUITING
Aswān
Contact Information
Primary
Gehad Adel Abd El-Sabour, M.D
gehada022@gmail.com
+201000415446
Time Frame
Start Date: 2024-07-10
Estimated Completion Date: 2025-07-10
Participants
Target number of participants: 60
Treatments
Group A: Leprosy Patients
About 30 patients affected with Leorosy
Group B: Healthy People
About 30 Healthy participants
Related Therapeutic Areas
Sponsors
Leads: Aswan University

This content was sourced from clinicaltrials.gov